Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor.

Ku, Bo Mi; Kim, Yeon Jeong; Park, Donghyun; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju; Sun, Jong-Mu

Ku, Bo Mi; Kim, Yeon Jeong; Park, Donghyun; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju; Sun, Jong-Mu.

Afiliación

Ku BM; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim YJ; Samsung Genomic Institute, Samsung Medical Center, Seoul, Republic of Korea.
Park D; GENINUS Inc., Seoul, Republic of Korea.
Lee SH; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ahn JS; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Park K; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ahn MJ; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Sun JM; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Oncology ; 100(4): 228-237, 2022.

Article en En | MEDLINE | ID: mdl-35196661

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; ADN Tumoral Circulante; Neoplasias Pulmonares; Biomarcadores de Tumor/genética; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/genética; Carcinoma de Pulmón de Células no Pequeñas/patología; ADN Tumoral Circulante/genética; Resistencia a Antineoplásicos/genética; Receptores ErbB/genética; Humanos; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/patología; Mutación; Inhibidores de Proteínas Quinasas/uso terapéutico

Palabras clave

Biomarker; Circulating tumor DNA; Liquid biopsy; Non-small cell lung cancer; Resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / ADN Tumoral Circulante / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Oncology Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google